This biotech and pharma support company sells at a reasonable PE of <19. It sports great profitability metrics including ROE >20% and profit margin > 15%. SIAL pays a dividend and yields just 1.2% but the payout has quadrupled in the last 10 years and doubled in the last 3. They are also buying back shares. What is not to like?Zz ∞
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Mornings